Proteomics analyses utilizing Ingenuity Pathway Analysis (IPA) of significant (p < 0.05, FC 1.5) proteins altered upon treatment with 10 μM of compound C3 suggested a predicted activation of tumor suppressor p53 pathways and a predicted deactivation of tumor promoter c-myc (Figure 8). The gene discussed is MYC; the disease is neoplasm.